| abstract |
The present invention relates to compounds useful as inhibitors of protein kinases. The present invention further provides methods for preparing the compounds of the invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various diseases. Specifically, the present invention also provides a pharmaceutical composition comprising a compound of formula I and a pharmaceutically acceptable carrier, adjuvant or excipient. Furthermore, the present invention also provides a method of treating or reducing the severity of a proliferative disease, condition or disorder in a patient. |